First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trialGareth J. Morgan, J. Anthony Child, A. John Ashcroft et al.|The Lancet|2010Cited by 571
Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX StudyAndy C. Rawstron, Roger G. Owen, J. A. Child et al.|Journal of Clinical Oncology|2013Cited by 419
Guidelines for the diagnosis and management of multiple myeloma 2011Jennifer M. Bird, Judith Behrens, Roger G. Owen et al.|British Journal of Haematology|2011Cited by 305
Guidelines for supportive care in multiple myeloma 2011John A. Snowden, Jennifer M. Bird, Sam H. Ahmedzai et al.|British Journal of Haematology|2011Cited by 209
Updates to the guidelines for the diagnosis and management of multiple myelomaGuy Pratt, Jennifer M. Bird, Matthew Jenner et al.|British Journal of Haematology|2014Cited by 25